Abstract
Objectives The purpose of this study was to assess utility scores of patients presenting to the emergency department (ED) with a musculoskeletal disorder and to explore the influence of diverse factors on health-related quality of life.
Design Secondary analysis of data obtained before randomization during a pragmatic randomized controlled trial
Setting Academic ED in Quebec City (Canada)
Participants Participants aged 18-80 years old presenting with a minor MSKD.
Main Outcome Measures Health-related quality of life (five dimensions: mobility, self-care, usual activities, pain/discomfort, and anxiety/depression) and utility scores (0 – dead, 100 – perfect health), measured with the EQ-5D-5L, were compared between subgroups and with reference values using descriptive statistics (mean, median), rankFD ANOVAs, and χ2 tests.
Results Sixty-nine participants completed the EQ-5D-5L. Mean and median utility scores were respectively 0.536 (95% CI: 0.479-0.594) and 0.531 (IQR: 0.356-0.760). Participants with higher levels of pain (<4/10: 0.741; 4-7/10: 0.572; >7/10: 0.433) or pain interference on function (<4/10: 0.685; 4-7/10: 0.463; >7/10: 0.294) presented significantly lower utility scores. No significant differences were found for other socio-demographic characteristics. The mean overall VAS score was 58.1 (95% CI: 52.2-64.0).
Conclusions In patients with MSKDs presenting to the ED, higher levels of pain and pain interference on function may influence perceived health-related QoL. These findings need to be confirmed on a larger scale.
Trial Registration This trial was registered at the US National Institutes of Health (ClinicalTrials.gov) #NCT04009369 on July 5, 2019
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
NCT04009369
Funding Statement
Funding for this project was provided by the CHU de Québec-Université Laval, subsidies from LJH and KP and a research grant awarded by the multidisciplinary council of the CHU de Québec – Université Laval in association with the Fondation du CHU de Québec. RG received scholarships from the Canadian Institutes of Health Research, the CIRRIS, the Ordre professionnel de la physiothérapie du Québec and the Department of Rehabilitation funds of the Faculty of Medicine at Université Laval. KP and JRG are Fonds de recherche du Québec-Santé (FRSQ) Junior 1 Research Scholars.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
This trial was approved by the Research Ethics Committee of the CHU de Québec - Université Laval #MP-20-2019-4307
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data that support the findings of this study are available from the corresponding author, LJH, upon reasonable request.
